 |
|||
| ABX-CRO has successfully conducted several EMEA Orphan Status applications for both diagnostic and therapeutic products. Design of Drug Development plans in compliance with latest regulatory requirements, or implementation of scientific advice meetings with European health authorities or the US FDA, are among the most sensitive contract services in the drug development industry. Senior experts, with a sound drug development track record for big pharma and biotech companies alike, help you to professionally and competently address even delicate authority interactions. For diagnostic or therapeutic radiopharmaceutical products, ABX-CRO´s unsurpassed specialist services are used by many important manufacturers in the field. |
|||
